Filing Details

Accession Number:
0000921895-22-000885
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-16 08:35:24
Reporting Period:
2022-03-15
Accepted Time:
2022-03-16 08:35:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1497504 Plx Pharma Inc. PLXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315585 Natasha Giordano 9 Fishers Lane
Suite E
Sparta NJ 07871
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-15 4,100 $3.65 5,186 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct